Interleukin 2 regulation following semi-allogeneic bone marrow transplantation in mice

Cancer Immunol Immunother. 2006 Nov;55(11):1330-6. doi: 10.1007/s00262-006-0125-y. Epub 2006 Feb 1.

Abstract

Success of allogeneic and autologous bone marrow transplantation (BMT) is hampered by susceptibility to infection during the first two post-treatment years. Further, in treating malignant diseases, impaired anti-host reactivity for donor cells may contribute to a high rate of relapse. Both complications are a consequence of immune deficiency involving B and T lymphocytes. The present study evaluates several key parameters of the immunologic reconstitution mechanism in mice subjected to myeloablative total body irradiation following semi-allogeneic (parental) BMT. This resulted in a gradual reduction of splenic CD3, CD4 and CD8 cells until day 45 post-BMT. Concomitantly, there was an increase in monocytes and CD4+/CD8+ (double positive) cells, accompanied by a persistent elevation in the percentage of B lymphocytes. The total thymic and splenic T cell populations were reduced until day +30. The cellular reduction correlated with the poor proliferative response of the thymic and splenic cells. A decrease occurred in IL-2 mRNA expression in thymic cells during days 15-20 post-transplant, corresponding with the low level of IL-2 secretion in the spleen and thymus of the transplanted mice. In conclusion, following semi-allogeneic BMT, there was an overall immune down-regulation in the cells, gene and protein levels. Reduced immunological responsiveness following BMT reinforces the need for improving the immune dysfunction by immunotherapy post-BMT.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow Transplantation
  • Female
  • Gene Expression Regulation*
  • Immune System
  • Interleukin-2 / biosynthesis
  • Interleukin-2 / metabolism
  • Interleukin-2 / physiology*
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Phenotype
  • RNA, Messenger / metabolism
  • Spleen / metabolism*
  • T-Lymphocytes / metabolism
  • Thymus Gland / metabolism*
  • Transplantation, Homologous

Substances

  • Interleukin-2
  • RNA, Messenger